Study of IRNEA (Irinotecan, Etoposide, Cytarabine) for Refractory or Relapsed Acute Leukemia in Children and Adolescents
Clinical trial NCT01239485 · UNKNOWN
Trial details
- NCT number
- NCT01239485
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2013-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.